CD39-L4 - Hyseq
Latest Information Update: 19 Aug 2002
At a glance
- Originator Nuvelo
- Class
- Mechanism of Action Enzyme replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Myocardial infarction; Stroke
Most Recent Events
- 19 Aug 2002 Discontinued - Preclinical for Myocardial infarction in USA (unspecified route)
- 19 Aug 2002 Discontinued - Preclinical for Stroke in USA (unspecified route)
- 05 Apr 2000 Preclinical development for Myocardial infarction in USA (Unknown route)